1. Home
  2. RGEN vs BBWI Comparison

RGEN vs BBWI Comparison

Compare RGEN & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BBWI
  • Stock Information
  • Founded
  • RGEN 1981
  • BBWI 1963
  • Country
  • RGEN United States
  • BBWI United States
  • Employees
  • RGEN N/A
  • BBWI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BBWI Clothing/Shoe/Accessory Stores
  • Sector
  • RGEN Health Care
  • BBWI Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • BBWI Nasdaq
  • Market Cap
  • RGEN 7.6B
  • BBWI 6.7B
  • IPO Year
  • RGEN N/A
  • BBWI N/A
  • Fundamental
  • Price
  • RGEN $124.73
  • BBWI $31.54
  • Analyst Decision
  • RGEN Buy
  • BBWI Buy
  • Analyst Count
  • RGEN 11
  • BBWI 17
  • Target Price
  • RGEN $190.25
  • BBWI $41.71
  • AVG Volume (30 Days)
  • RGEN 661.4K
  • BBWI 5.3M
  • Earning Date
  • RGEN 11-12-2024
  • BBWI 11-25-2024
  • Dividend Yield
  • RGEN N/A
  • BBWI 2.54%
  • EPS Growth
  • RGEN N/A
  • BBWI 35.32
  • EPS
  • RGEN N/A
  • BBWI 4.14
  • Revenue
  • RGEN $639,915,000.00
  • BBWI $7,384,000,000.00
  • Revenue This Year
  • RGEN $0.44
  • BBWI N/A
  • Revenue Next Year
  • RGEN $12.13
  • BBWI $2.79
  • P/E Ratio
  • RGEN N/A
  • BBWI $7.61
  • Revenue Growth
  • RGEN N/A
  • BBWI N/A
  • 52 Week Low
  • RGEN $113.50
  • BBWI $26.21
  • 52 Week High
  • RGEN $211.13
  • BBWI $52.99
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 36.21
  • BBWI 55.05
  • Support Level
  • RGEN $137.27
  • BBWI $29.72
  • Resistance Level
  • RGEN $154.48
  • BBWI $32.10
  • Average True Range (ATR)
  • RGEN 7.09
  • BBWI 1.07
  • MACD
  • RGEN -0.55
  • BBWI 0.16
  • Stochastic Oscillator
  • RGEN 9.74
  • BBWI 80.68

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2023. For fiscal 2023, 74% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2022 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.

Share on Social Networks: